Table 1.
Characteristics of patients in the study.
| AF (n = 24) | nAF (n = 24) | P value | |
|---|---|---|---|
| Gender (m/f) | 10/14 | 9/15 | 0.768 |
| Age (years) | 55.33 ± 7.88 | 54.58 ± 11.53 | 0.794 |
| BMI | 23.25 ± 2.82 | 23.48 ± 3.42 | 0.806 |
| NYHA class (n, I/II/III/IV) | 0/3/20/1 | 0/3/18/3 | 0.541 |
| White cell (*10^9/L) | 5.66 ± 1.77 | 5.99 ± 1.51 | 0.492 |
| Neutrophil (*10^9/L) | 3.51 ± 1.39 | 3.75 ± 1.14 | 0.521 |
| Lymphocyte (*10^9/L) | 1.44 ± 0.58 | 1.53 ± 0.55 | 0.611 |
| Blood glucose (mmol/l) | 6.01 ± 1.46 | 5.88 ± 1.98 | 0.799 |
| TG (mmol/l) | 1.55 ± 0.74 | 1.83 ± 1.91 | 0.542 |
| TC (mmol/l) | 3.90 ± 0.97 | 4.45 ± 1.26 | 0.115 |
| HDL (mmol/l) | 0.90 ± 0.16 | 1.07 ± 0.26 | 0.013 |
| LDL (mmol/l) | 2.49 ± 0.73 | 2.72 ± 0.76 | 0.319 |
| CRP (mg/l) | 11.04 ± 19.61 | 17.86 ± 38.43 | 0.442 |
| ESR (mm/h) | 34.61 ± 27.69 | 27.73 ± 26.11 | 0.396 |
| NTproBNP (pg/ml) | 4118.52 ± 5309.2 | 3061.83 ± 2997.09 | 0.408 |
| EF (%) | 52.17 ± 11.42 | 54.75 ± 9.06 | 0.599 |
| RVD (mm) | 15.92 ± 4.62 | 16.63 ± 2.80 | 0.524 |
| LVD (mm) | 47.96 ± 10.39 | 48.21 ± 8.93 | 0.929 |
| LAD (mm) | 48.88 ± 8.34 | 38.50 ± 8.70 | 0.004 |
| RAD (mm) | 48.50 ± 9.82 | 43.00 ± 8.48 | 0.043 |
| Smoking (n, %) | 7 (29.17%) | 5 (20.83%) | 0.505 |
| Drinking (n, %) | 2 (8.33%) | 4 (16.67%) | 0.383 |
| Hypertension (n, %) | 5 (20.83%) | 5 (20.83%) | 1 |
| CHD (n, %) | 7 (29.17%) | 3 (12.5%) | 0.155 |
| Diabetes (n, %) | 3 (12.5%) | 0 (0%) | 0.074 |
| Digitalis (n, %) | 20 (83.33%) | 15 (62.5%) | 0.104 |
| Amiodarone (n, %) | 3 (12.5%) | 0 (0%) | 0.074 |
| ACEI (n, %) | 2 (8.33%) | 2 (8.33%) | 1 |
| ARB (n, %) | 1 (4.16%) | 1 (4.16%) | 1 |
| β-blocker (n, %) | 12 (50%) | 17 (70.83%) | 0.140 |
| Ca2+ antagonist (n, %) | 12 (50%) | 9 (37.5%) | 0.383 |
| Statin (n, %) | 3 (12.5%) | 3 (12.5%) | 1 |
Abbreviations used in table 1: BMI body mass index, NYHA class New York Heart Association class, TG triglyceride, TC total cholesterol, HDL high-density lipoprotein, LDL low-density lipoprotein, CRP C-reactive protein, ESR erythrocyte sedimentation rate, NTproBNP N-terminal pro B-type-natriuretic peptide, EF ejection fraction, RVD right ventricular dimension, LVD left ventricular dimension, LAD left atrial dimension, RAD right atrial dimension, CHD coronary heart disease, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blocker